The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Drug Manufacturers - Other > AVI BioPharma Inc.

AVI BioPharma Inc.
Nasdaq: AVII
Change
symbol:
     
 PROFILE
AVI BioPharma (formerly Antivirals, Inc.) develops therapeutic and gene-targeted treatments for cancer and heart disease. Its lead product, Avicine, reacts against the human chorionic gonadotropin (hCG) hormone, which is present in most cancers; the drug continues in clinical trials, specifically for cancer of the colon, prostate, and pancreas. AVI's gene-targeted drugs, NEU-GENES, block the function of certain genetic sequences to treat bone cancer and restenosis, a cardiovascular disease. The firm has also licensed XenoMouse technology from Abgenix to develop antibodies as companions to Avicine. Biotech firm SuperGen has bought the marketing rights to Avicine.

 COMPETITION
Boehringer Ingelheim GmbH (dossier)
Bristol-Myers Squibb Company (BMY)
GlaxoSmithKline plc (GSK)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 1.30
1-Yr. Sales Growth: 1,200.0%
Employees: 71
Revenue per employee: $18,309.86

 KEY PEOPLE
• Denis R. Burger
    CEO
• Mark M. Webber
    CFO

 CONTACT INFO
1 SW Columbia, Ste. 1105
Portland, OR 97258
US
Phone: 503-227-0554
Fax: 503-227-0751
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001